Skip to main content
CSL Seqirus Logo Red
  • Partnering
  • Contact
  • Our Company
    Our Company
    Corporate Responsibility
    Corporate Responsibility
    Disclosures
    Leadership

    Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core.

    Learn more

    At Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.

    Learn more
  • Expertise
    Expertise
    Influenza
    Influenza
    Pandemic Response Solutions
    Antivenom & Q fever Vaccines
    In-licensing

    Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia.

    Learn more

    Seqirus is on the front line of battling influenza, working hard to suppress costly and life-threatening epidemics and pandemics. Vaccination is the most effective way to prevent influenza .

    Learn more
  • R&D
    R&D
    Research Practices
    Investigator Initiated Studies

    Our Seqirus research and development group provides support to ensure the conditions are optimised for efficient vaccine manufacture. Activities also focus on improving the effectiveness of current influenza vaccines and their manufacturing processes.

    Learn more

    At Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice.

    Learn more
  • Manufacturing
    Manufacturing
    Global Manufacturing Network
    Technologies
    Technical Development
    Quality & Safety

    One of the largest influenza vaccine companies in the world, Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world.

    Learn more

    Seqirus utilises both egg and cell-based production technologies and we offer a broadest portfolio of influenza vaccines. We have commercialised the only adjuvanted seasonal influenza vaccine for older adults and paediatrics and offer two different types of quadrivalent influenza vaccines.

    Learn more
  • Products
  • Careers
    Careers
    See Yourself at Seqirus
    Discover Our People
    Diversity and Inclusion
    How we care for you at Seqirus

    When you join Seqirus, you join a team dedicated to protecting people and communities from influenza. It's a feeling of purpose and possibility that inspires us every day.

    Learn more

    It doesn't matter whether you are a scientist or an administrator, a marketer or an operator - as long as you are inspired by the chance to create something that will help others, you can find your role at Seqirus.

    Learn more
Seqirus
  • Our Company
    • Our Company
    • Corporate Responsibility
      • Corporate Responsibility
      • Disclosures
    • Leadership
  • Expertise
    • Expertise
    • Influenza
      • Influenza
      • Pandemic Response Solutions
    • Antivenom & Q fever Vaccines
    • In-licensing
  • R&D
    • R&D
    • Research Practices
    • Investigator Initiated Studies
  • Manufacturing
    • Manufacturing
    • Global Manufacturing Network
    • Technologies
    • Technical Development
    • Quality & Safety
  • Products
  • Careers
    • Careers
    • See Yourself at Seqirus
    • Discover Our People
    • Diversity and Inclusion
    • How we care for you at Seqirus
  • Partnering
  • Contact
  • Seqirus
  • Our Company
  • Corporate Responsibility
  • Disclosures

DISCLOSURES

Transparency reporting

As a member of Medicines New Zealand, Seqirus (NZ) Ltd, promotes transparency in its relationships with Healthcare Professionals and is committed to ensuring that any transfers of value (TOV) between Seqirus and health professionals is both appropriate and transparent. Seqirus’ ethical and transparent commitment to support healthcare professional education means that patients can be even more confident that they are receiving the best of care.

Healthcare Professional Transfers of Value and Transparency Reports

Seqirus supports healthcare professional education to advance and improve patient health in New Zealand. Increased transparency will reassure the New Zealand community that these payments are appropriate and that healthcare professionals will continue to put patients’ interests first.

Reportable payments to Healthcare Professionals are:

  • Payments for the provision of services such as giving a lecture, chairing an educational meeting, speaking engagement, providing advice as a member of an Advisory Board or as a Consultant
  • Sponsorship to attend medical education (airfares, accommodation, conference registration fees)
  • Direct payments to a healthcare professional as well as indirect payments to a healthcare professional via a healthcare organisation for any of the above.

Seqirus is publishing its Healthcare Professional Transfers of Value reports on this website in PDF format in a manner consistent with New Zealand’s Privacy legislation.

For further information about transparency reporting, please visit https://www.medicinesnz.co.nz/

Healthcare professional (HCP) and organisation (HCO) transparency reports

HCP Payments and Transfer of Value (TOV) Report for the period of 01 January 2021 to 31 December 2021

Seqirus Scientist

Our Company

We are a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally.

Learn more

NZL-CRP-21-0001

Corporate Responsibility

We conduct our business ethically and contribute to the economic, social and environmental well-being of our communities.

Learn more

Innovation

Innovation is vital to achieving our vision of a world protected from influenza.

Learn more

Career Opportunities

Join us in helping protect the world from influenza with the brightest, most passionate people from every discipline.

Learn more
On the Front Line
CSL Seqirus Logo White
  • Follow us on LinkedIn
  • Seqirus Instagram
  • Follow us on LinkedIn
  • Seqirus Instagram
  • Report an Adverse Event
  • Privacy Statement
  • Disclosures
  • Terms of Use
  • Cookie Policy
  • Sitemap

© 2022 Seqirus. All rights reserved. Seqirus is a trademark of Seqirus UK Limited or its affiliates.

Popular search terms:

  • Influenza Vaccines
  • Careers
  • Pandemic Preparedness
  • Expertise
Corporate
  • CSL Limited (Global)
Seqirus
  • Seqirus (Global)
  • Seqirus (Argentina)
  • Seqirus (Australia)
  • Seqirus (Canada)
  • Seqirus (Germany)
  • Seqirus (Italy)
  • Seqirus (New Zealand)
  • Seqirus (Spain)
  • Seqirus (US)